share_log

Shanghai General Healthy Information and Technology (SHSE:605186) Posted Weak Earnings But There Is More To Worry About

Shanghai General Healthy Information and Technology (SHSE:605186) Posted Weak Earnings But There Is More To Worry About

健麾信息(SHSE:605186)發佈業績疲軟,但還有更多令人擔憂的問題。
Simply Wall St ·  11/07 08:27

Shanghai General Healthy Information and Technology Co., Ltd.'s (SHSE:605186) weak earnings were disregarded by the market. Despite the market responding positively, we think that there are several concerning factors that investors should be aware of.

上海健麾信息科技有限公司(SHSE:605186)的營業收入表現疲弱,但市場並不在意。儘管市場做出了積極反應,我們認爲投資者應該注意到一些令人擔憂的因素。

big
SHSE:605186 Earnings and Revenue History November 7th 2024
SHSE:605186盈利和營業收入歷史數據 2024年11月7日

The Power Of Non-Operating Revenue

非營運收入的作用

Most companies divide classify their revenue as either 'operating revenue', which comes from normal operations, and other revenue, which could include government grants, for example. Oftentimes, non-operating revenue spikes are not repeated, so it makes sense to be cautious where non-operating revenue has made a very large contribution to total profit. However, we note that when non-operating revenue increases suddenly, it will sometimes generate an unsustainable boost to profit. It's worth noting that Shanghai General Healthy Information and Technology saw a big increase in non-operating revenue over the last year. Indeed, its non-operating revenue rose from CN¥24.2m last year to CN¥33.2m this year. If that non-operating revenue fails to manifest in the current year, then there's a real risk the bottom line profit result will be impacted negatively. In order to better understand a company's profit result, it can sometimes help to consider whether the result would be very different without a sudden increase in non-operating revenue.

大多數公司將其營業收入劃分爲'營業收入',來自正常業務運營,以及其他收入,可能包括政府補助等。通常,非營業收入的激增並不會重複出現,因此在非營業收入對總利潤貢獻較大時保持謹慎是明智的。然而,我們注意到,當非營業收入突然增加時,有時會給利潤帶來不可持續的提升。值得注意的是,上海健麾信息科技去年非營業收入顯著增加。事實上,其非營業收入從去年的2420萬人民幣增加到今年的3320萬人民幣。如果這種非營業收入在當前年度未顯現,那麼底線利潤結果將受到實質性負面影響。爲了更好地了解一家公司的利潤結果,有時可以考慮在沒有非營業收入突然增加的情況下,結果會有何不同。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。

How Do Unusual Items Influence Profit?

非常規項目如何影響利潤?

Alongside that spike in non-operating revenue, it's also important to note that Shanghai General Healthy Information and Technology'sprofit was boosted by unusual items worth CN¥14m in the last twelve months. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Shanghai General Healthy Information and Technology had a rather significant contribution from unusual items relative to its profit to September 2024. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

除了非營業收入的激增外,還值得注意的是,上海健麾信息科技在過去12個月中由於價值1400萬人民幣的飛凡項目而增加了利潤。雖然盈利增加總是令人高興的,但有時來自飛凡項目的巨額貢獻會抑制我們的熱情。當我們分析全球大多數上市公司時,我們發現重大的飛凡項目通常不會再次出現。畢竟,這正是會計術語所暗示的。相較於2024年9月的利潤,上海健麾信息科技的飛凡項目貢獻相當顯著。因此,我們可以推斷,飛凡項目使其法定利潤比原本強勁得多。

Our Take On Shanghai General Healthy Information and Technology's Profit Performance

我們對上海健麾信息的利潤表現進行了分析

In its last report Shanghai General Healthy Information and Technology benefitted from a spike in non-operating revenue which may have boosted its profit in a way that may be no more sustainable than low quality coal mining. And on top of that, it also saw an unusual item boost its profit, suggesting that next year might see a lower profit number, if these events are not repeated and everything else is equal. Considering all this we'd argue Shanghai General Healthy Information and Technology's profits probably give an overly generous impression of its sustainable level of profitability. If you'd like to know more about Shanghai General Healthy Information and Technology as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 2 warning signs for Shanghai General Healthy Information and Technology you should be aware of.

在最近的報告中,上海健麾信息受益於非營業收入的激增,這可能提高了其利潤,這種方式可能比低質量的煤炭開採更不可持續。 除此之外,另一個飛凡項目也提高了其利潤,這表明如果這些事件不再發生且其他所有條件相同的話,明年的利潤數字可能會較低。 考慮到所有這些情況,我們認爲上海健麾信息的利潤可能過於慷慨地體現了其可持續盈利水平。 如果您想了解上海健麾信息作爲業務實體的更多信息,了解其所面臨的風險是很重要的。 舉個例子:我們已經發現了上海健麾信息存在2個警示信號,您應該注意。

Our examination of Shanghai General Healthy Information and Technology has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

我們對上海健麾信息的檢查集中在一些因素上,使其盈利看起來比實際情況更好。基於此,我們有些懷疑。 但如果您能集中精力關注細微之處,總會有更多發現。 例如,許多人認爲高淨資產回報率是有利的商業經濟指標,而另一些人喜歡「跟隨資金」並尋找內部人員在買入的股票。 儘管這可能需要您進行一些研究,但您可能會發現這個免費的公司收藏,其中包含具有高淨資產回報率的公司,或者這個持有重要內部股權的股票列表是有用的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論